Delek Logistics Partners, LP (NYSE:DKL), which plays a critical role in the energy supply chain, just hit a milestone that almost no MLP can claim: 52 consecutive quarterly distribution increases spanning 13 consecutive years of distribution growth. The current annualized payout of ~$4.50 per unit, against a recent unit price of $52.76, translates to an 8.53% yield, which ranks among the highest in its peer group. But a closer look at the cash flow mechanics raises a legitimate question about whether that streak reflects financial strength or financial engineering.
Delek Logistics Partners (DKL)
The Streak Is Real. The Coverage Is Not.
President Avigal Soreq called the milestone “an extraordinary achievement,” reflecting “financial prudence.” The operational story does support a certain level of optimism as full-year 2025 adjusted EBITDA hit a record $536 million, with each quarter setting a new high, from $116.54M in Q1 to $142.28M in Q4. Delaware Basin crude gathering volumes reached 153,745 barrels per day in Q3 2025, up from 125,123 bpd a year earlier, and water disposal volumes nearly doubled to 616,484 bpd.
The cash flow picture tells a more complicated story, especially in 2025, when the operating cash flow of $237.1M barely covered dividend payouts of $238.1M, resulting in a coverage ratio of essentially 1.0x. Capital expenditures of $267.8M exceeded operating cash flow entirely and were funded through capital markets. At the quarterly level, Q4 2025 was starker: operating cash flow of $31M covered only about half the $59.9M in distributions paid that quarter. The Q4 2025 adjusted distributable cash flow coverage ratio was approximately 1.22x, a metric that adds back non-cash items while still reflecting a lean business.
Leverage and Analyst Divergence
Total debt stands at approximately $2.3 billion against a leverage ratio of ~4.07x as of Q4 2025, an improvement from the 4.44x peak in Q3. Somewhat concerning to shareholders is that their equity has eroded to just $6.11M, and the reported payout ratio sits at 136.78%. CFO Robert Wright acknowledged the tension directly: “While we are driving meaningful financial and operational growth across the partnership, we remain equally focused on achieving our long-term leverage and coverage objectives.”
When it comes to what think analysts think, there is some split thinking as Citigroup moved to Neutral in March 2026 with a $52 price target, citing the recent earnings miss and “limited growth potential.” Raymond James took the opposite view, maintaining an Outperform rating and raising its target to $55, citing cash flow growth and operational execution. For the moment, the consensus sits at Hold.
What to Watch
The bull case hinges on the Libby Complex sour gas and acid gas injection buildout, which management describes as a “step change” in utilization and a multi-year growth engine for the Delaware Basin. The 2026 EBITDA guidance range of $520M to $560M, even absorbing a ~$10M Winter Storm Fern hit in Q1, would represent continued EBITDA growth. If guidance is met and leverage continues declining toward management’s stated targets, the distribution streak has a credible path forward. If capex remains elevated and coverage stays thin, the 53rd increase will be a harder sell.
Top Gaining Stocks
Top Losing Stocks